News

Max Healthcare Institute Ltd share price gained 1% to Rs 860.0 after the company`s net profit jumped 28.33% to Rs 414.45 crore, while revenue from operations slightly gained 8.58% to Rs 2569.21 crore in Q3FY26 over Q2FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.88 lakh crore, easing 7.72%. It has marginally improved by 8.07% over last one week and gained upto 2.85% in last one month while the market capitalization of Max Healthcare Institute Ltd has improved by 5.26% and 21.71% in the same period respectively. Profit before tax (PBT) of Max Healthcare Institute Ltd stood at Rs 540.92 crore in Q3 FY26, rallying 21.27% year-on-year, and expanding by 23.98% quarter-on-quarter. EBITDA came in at Rs 671 crore, surging by 23.67% YoY and jumping 20.19% sequentially. Total expenses grew marginally by 5.05% to Rs 1995.35 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 521.94 crore, inching up 0.15% YoY, while employee benefits expense was at Rs 399.31 crore, ticking higher by 2.87% YoY. For the TTM ended FY26, revenue from operations grew 19.14% to Rs 8373.45 crore, while net profit soared by 34.07% to Rs 1442.41 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 177927% to Rs 2080.21 crore, and PBT registered a growth of 19.14% to Rs 1675.58 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 1633.32 crore in FY26, as against Rs 1459.31 crore in FY25. Max Healthcare Institute Ltd crashed 27% in last one year, underperforming the benchmark BSE Sensex which has reduced by 11.78% during the same period.

Max Healthcare Institute Ltd share price gained 0.17% to Rs 851.45 after the company`s net profit surged by 28.33% to Rs 414.45 crore, while revenue from operations slightly gained 8.58% to Rs 2569.21 crore in Q3FY26 over Q2FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.88 lakh crore, rising 7.39%. It has marginally improved by 6.60% over last one week and ticked higher by 1.45% in last one month while the market capitalization of Max Healthcare Institute Ltd has inched up 4.22% and 22.49% in the same period respectively. Profit before tax (PBT) of Max Healthcare Institute Ltd stood at Rs 540.92 crore in Q3 FY26, rallying 21.27% year-on-year, and expanding by 23.98% quarter-on-quarter. EBITDA came in at Rs 671 crore, surging by 23.67% YoY and jumping 20.19% sequentially. Total expenses saw a slight increase of 5.05% to Rs 1995.35 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 521.94 crore, posting a minor increase of 0.15% YoY, while employee benefits expense was at Rs 399.31 crore, inching up 2.87% YoY. For the TTM ended FY26, revenue from operations grew 19.14% to Rs 8373.45 crore, while net profit jumped 34.07% to Rs 1442.41 crore, compared to previous TTM. EBITDA jumped by 177927% to Rs 2080.21 crore, and PBT rose 19.14% to Rs 1675.58 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 1633.32 crore in FY26, as against Rs 1459.31 crore in FY25. Max Healthcare Institute Ltd nosedived by 28.43% in last one year, underperforming the benchmark BSE Sensex which has slipped by 12.76% during the same period.

Max Healthcare Institute Limited announced that its Nomination & Remuneration Committee approved the allotment of 16,803 equity shares with a face value of Rs 10 each to eligible employees under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Consequently, the company`s paid-up equity share capital increased to Rs 973,32,70,540 from Rs 973,31,02,510.

Max Healthcare Institute Limited will close the trading window for securities from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company’s code of conduct.

Max Healthcare Institute Limited announced that its Nomination & Remuneration Committee approved the allotment of 33,765 equity shares with a face value of Rs 10 each to eligible employees under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. The allotment, which occurred on September 4, 2026, increased the company’s paid-up equity share capital to Rs 973,31,02,510 and total issued share capital to 97,33,10,251 equity shares.